EP 1357914 A2 20031105 - TREATMENT OF PPAR MEDIATED DISEASES
Title (en)
TREATMENT OF PPAR MEDIATED DISEASES
Title (de)
VERFAHREN ZUR BEHANDLUNG VON PPAR VERMITTELTEN KRANKHEITEN
Title (fr)
REGIMES THERAPEUTIQUES
Publication
Application
Priority
- US 0203017 W 20020131
- US 26639301 P 20010202
Abstract (en)
[origin: WO02070011A2] This invention provides a method for identifying a treatment regime for a compound or composition effective in treating a PPAR mediated disease or condition. The method includes determingin a treatment regime for the compound or composition that causes expression of a surrogate market for PPAR delta activity whereby the determined dose and route of administration identifies an effective treatment protocol.
IPC 1-7
A61K 31/421; A61K 31/426; A61P 3/04; A61P 3/06; A61P 3/10; A61P 9/00
IPC 8 full level
A61K 38/17 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP)
A61K 38/1783 (2013.01); A61P 3/04 (2017.12); A61P 3/06 (2017.12); A61P 3/10 (2017.12); A61P 9/00 (2017.12); G01N 33/566 (2013.01); G01N 2333/70567 (2013.01); G01N 2500/00 (2013.01)
Citation (search report)
See references of WO 02070011A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02070011 A2 20020912; WO 02070011 A3 20030424; AU 2002243778 A1 20020919; EP 1357914 A2 20031105
DOCDB simple family (application)
US 0203017 W 20020131; AU 2002243778 A 20020131; EP 02709285 A 20020131